Wells Fargo is collaborating with the National Center for the Middle Market (NCMM) at The Ohio State University Max M.

In a report released yesterday, Cerena Chen from Wells Fargo maintained a Buy rating on Axsome Therapeutics, with a price target of $165.00. The company’s shares closed yesterday at $106.54. Take ...

Fintel reports that on August 6, 2025, Wells Fargo upgraded their outlook for Incyte (NasdaqGS:INCY) from Equal-Weight to ...

Fintel reports that on August 6, 2025, Wells Fargo upgraded their outlook for Vertex Pharmaceuticals (NasdaqGS:VRTX) from ...

Analysts have recently evaluated Gartner and provided 12-month price targets. The average target is $364.6, accompanied by a ...

Discover key takeaways from Mosaic's Q2 2025 earnings call, featuring asset reliability upgrades, rising potash production, and EBITDA growth projections.

Net income: $75.5 million, or $2.06 per diluted share, compared to $44.4 million, or $1.21 per share, for Q2 2024; the prior period included a net negative impact of $8 million, or $0.22 per share, ...

Amgen Inc. (NASDAQ:AMGN) shares are trading lower on Wednesday, despite the company reporting second-quarter results that ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

The pivot to a more decidedly downbeat assessment in the economic data is the top-of-the-fold headline in August, but fiscal policy is set to be a tailwind for economic activity at the start of next ...